Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS program.

BACKGROUND The long-term impact of treating de novo coronary lesions in native vessels and challenging small vessel and long lesion subsets with TAXUS Liberté stents is unknown. This report examines the 3-year efficacy and safety from the TAXUS ATLAS program. METHODS AND RESULTS TAXUS ATLAS WH, Small Vessel, and Long Lesion are non-randomized studies… CONTINUE READING